Characteristics | COPD (n = 200) | No COPD (n = 201) | P-value |
---|---|---|---|
Age, years | 66 (61-70) | 65 (61-70) | 0.258 |
Male sex | 178 (89) | 172 (86) | 0.369 |
BMI (kg/m2) | 27 (24-31) | 28 (25-30) | 0.508 |
Current smoker | 97 (49) | 101 (50) | 0.766 |
Pack-years of smoking | 48 (39-60) | 40 (33-50) | <0.001 |
FEV1, % predicted | 54 (42-65) | 95 (88-105) | <0.001 |
DLCO, % predicted | 76 (58-86) | 96 (86-108) | <0.001 |
Chronic mucous hypersecretion | 116 (58) | 46 (23) | <0.001 |
Chronic cor pulmonale | 47 (24) | 0 (0) | <0.001 |
Emphysema | 87 (44) | 0 (0) | <0.001 |
Comorbidity | Â | Â | Â |
Systemic arterial hypertension | 95 (48) | 75 (37) | 0.043 |
Coronary artery disease | 59 (30) | 55 (27) | 0.659 |
Heart failure | 23 (12) | 13 (6.5) | 0.083 |
Dilated cardiomyopathy | 6 (3) | 6 (3) | 1.000 |
Left heart valvular disease | 8 (4) | 5 (2.5) | 0.416 |
Chronic atrial fibrillation | 10 (5) | 7 (3.5) | 0.470 |
Prior stroke | 2 (1) | 3 (1.5) | 1.000 |
Prior PE or DVT | 5 (2.5) | 3 (1.5) | 0.503 |
Renal failure | 0 (0) | 0 (0) | 1.000 |
Diabetes mellitus | 22 (11) | 30 (15) | 0.298 |
Dyslipidemia | 61 (31) | 74 (37) | 0.205 |
Thyroid dysfunction | 18 (9) | 11 (5.5) | 0.183 |
Chronic hepatitis C | 7 (3.5) | 9 (4.5) | 0.799 |
Therapy | Â | Â | Â |
Inhaled bronchodilators | 139 (70) | 0 (0) | <0.001 |
Inhaled corticosteroids | 128 (64) | 0 (0) | <0.001 |
Oral theophylline | 48 (24) | 0 (0) | <0.001 |
Long-term oxygen | 7 (3.5) | 0 (0) | 0.007 |
Cardiovascular drugs | 122 (61) | 108 (54) | 0.158 |
Diuretics | 52 (26) | 30 (15) | 0.006 |
Warfarin | 15 (8) | 10 (5) | 0.311 |
Statins | 37 (19) | 47 (23) | 0.269 |
Oral hypoglicemic drugs/insulin | 17 (9) | 21 (10) | 0.609 |
Thyroid replacement therapy | 7 (3.5) | 4 (2) | 0.380 |